المؤلفون: Martín M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain., Yoder R; The University of Kansas Cancer Center, Westwood, Kansas., Salgado R; ZAS Hospitals, Antwerp, Belgium., Del Monte-Millán M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Álvarez EL; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Echavarría I; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Staley JM; The University of Kansas Cancer Center, Westwood, Kansas., O'Dea AP; University of Kansas Medical Center, Westwood, Kansas., Nye LE; University of Kansas Medical Center, Westwood, Kansas., Stecklein SR; University of Kansas Medical Center, Kansas City, Kansas., Bueno C; Hospital Infanta Cristina (Parla), Madrid, Spain., Jerez Y; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Cebollero M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Bueno O; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., García Saenz JÁ; Hospital Clínico San Carlos, Madrid, Spain., Moreno F; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain., Bohn U; Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Canary Islands., Gómez H; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Massarrah T; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Khan QJ; University of Kansas Medical Center, Westwood, Kansas., Godwin AK; University of Kansas Medical Center, Kansas City, Kansas., López-Tarruella S; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain., Sharma P; University of Kansas Medical Center, Westwood, Kansas.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2160-2169.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Lymphocytes, Tumor-Infiltrating*/immunology , Neoadjuvant Therapy*/methods , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/mortality , Triple Negative Breast Neoplasms*/pathology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Middle Aged ; Adult ; Aged ; Anthracyclines/administration & dosage ; Anthracyclines/therapeutic use ; Prognosis ; Neoplasm Staging ; Treatment Outcome ; Docetaxel/administration & dosage ; Docetaxel/therapeutic use ; Carboplatin/administration & dosage

المؤلفون: Sharma P; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Stecklein SR; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City.; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City., Yoder R; The University of Kansas Cancer Center, Kansas City., Staley JM; The University of Kansas Cancer Center, Kansas City., Schwensen K; Department of Internal Medicine, University of Kansas Medical Center, Westwood., O'Dea A; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Nye L; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Satelli D; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Crane G; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Madan R; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City., O'Neil MF; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City., Wagner J; Department of Surgery, University of Kansas Medical Center, Kansas City., Larson KE; Department of Surgery, University of Kansas Medical Center, Kansas City., Balanoff C; Department of Surgery, University of Kansas Medical Center, Kansas City., Kilgore L; Department of Surgery, University of Kansas Medical Center, Kansas City., Phadnis MA; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City., Godwin AK; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City.; The University of Kansas Cancer Center, Kansas City., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter Mac Callum Canter Centre, Melbourne, Australia., Khan QJ; Department of Internal Medicine, University of Kansas Medical Center, Westwood., O'Shaughnessy J; Baylor University Medical Center, Dallas, Texas.

المصدر: JAMA oncology [JAMA Oncol] 2024 Feb 01; Vol. 10 (2), pp. 227-235.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/genetics , Antibodies, Monoclonal, Humanized*, Humans ; Female ; Middle Aged ; Docetaxel/therapeutic use ; Carboplatin/therapeutic use ; Neoadjuvant Therapy/methods ; B7-H1 Antigen ; Neoplasm, Residual/chemically induced ; Neoplasm, Residual/drug therapy ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers ; Anthracyclines/therapeutic use ; Tumor Microenvironment

المؤلفون: Machiels M; Department of Radiation Oncology, Iridium Netwerk, University of Antwerp, Health & Sciences, Antwerp, Belgium. Electronic address: Melanie.Machiels@gza.be., Oulkadi R; Department of Radiation Oncology, Iridium Netwerk, University of Antwerp, Health & Sciences, Antwerp, Belgium., Tramm T; Department of Pathology, Aarhus University Hospital, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Stecklein SR; Departments of Radiation Oncology, Pathology & Laboratory Medicine, And Cancer Biology, The University of Kansas Medical Center, KS, USA., Somaiah N; Division of Radiotherapy and Imaging, The Institute of Cancer Research, Breast Unit, The Royal Marsden NHS Foundation Trust, UK., De Caluwé A; Université Libre de Bruxelles (ULB), Hôpitaux Universitaires de Bruxelles (H.U.B), Institut Jules Bordet, Brussels, Belgium., Klein J; State University of New York (SUNY) Downstate Health Sciences University and Maimonides Medical Center, NY, United States., Tran WT; Department of Radiation Oncology, University of Toronto & Sunnybrook Health Sciences Centre, Toronto, Canada., Salgado R; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Pathology, GZA - ZNA Hospitals, Antwerp, Belgium.

المصدر: Breast (Edinburgh, Scotland) [Breast] 2023 Oct; Vol. 71, pp. 13-21. Date of Electronic Publication: 2023 Jul 01.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/radiotherapy , Breast Neoplasms*/drug therapy, Humans ; Female ; Lymphocytes, Tumor-Infiltrating ; Prognosis ; Biomarkers, Tumor/genetics ; Genomics

المؤلفون: Stecklein SR; University of Kansas Medical Center, Kansas City, KS., Barlow W; SWOG Statistical Center, Seattle, WA., Pusztai L; Yale Cancer Center, New Haven, CT., Timms K; Myriad Genetics, Inc, Salt Lake City, UT., Kennedy R; Almac Diagnostic Services, Craigavon, Northern Ireland, United Kingdom.; Patrick G Johnston Centre for Cancer Research, Queen's University of Belfast, Belfast, United Kingdom., Logan GE; Almac Diagnostic Services, Craigavon, Northern Ireland, United Kingdom., Seitz R; Oncocyte, Irvine, CA., Badve S; Emory University School of Medicine, Atlanta, GA., Gökmen-Polar Y; Emory University School of Medicine, Atlanta, GA., Porter P; Fred Hutchinson Cancer Center, Seattle, WA., Linden H; Fred Hutchinson Cancer Center, Seattle, WA., Tripathy D; MD Anderson Cancer Center, Houston, TX., Hortobagyi GN; MD Anderson Cancer Center, Houston, TX., Godwin AK; University of Kansas Medical Center, Kansas City, KS., Thompson A; Baylor College of Medicine, Houston, TX., Hayes DF; University of Michigan, Ann Arbor, MI., Sharma P; University of Kansas Medical Center, Kansas City, KS.

المصدر: JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300197.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/diagnosis , Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/drug therapy, Humans ; Prognosis ; Homologous Recombination/genetics ; DNA Damage/genetics ; Immunity ; Tumor Microenvironment

المؤلفون: Jagsi R; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia., Barlow WE; SWOG, University of Washington, Seattle, Washington., Woodward WA; University of Texas MD Anderson Cancer Center, Houston., Connolly E; Columbia University, New York, New York., Mahtani R; Baptist Health South Florida, Miami., Shumway D; Mayo Clinic, Rochester, Minnesota., Speers C; Case Western Reserve University, Cleveland, Ohio., Stecklein SR; University of Kansas, Kansas City., Zeidan Y; Baptist Health South Florida, Boca Raton., Zhang H; University of Rochester, Rochester, New York., Sharma P; University of Kansas, Kansas City., Pusztai L; Yale University, New Haven, Connecticut., Hortobagyi GN; University of Texas MD Anderson Cancer Center, Houston., Kalinsky K; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.

المصدر: JAMA oncology [JAMA Oncol] 2023 Aug 01; Vol. 9 (8), pp. 1083-1089.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/radiotherapy , Breast Neoplasms*/drug therapy, Humans ; Female ; Middle Aged ; Mastectomy ; Incidence ; Neoplasm Recurrence, Local/pathology ; Mastectomy, Segmental ; Radiotherapy, Adjuvant

المؤلفون: Stecklein SR; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Kimler BF; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA., Yoder R; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Schwensen K; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Staley JM; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Khan QJ; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., O'Dea AP; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Nye LE; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Elia M; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Heldstab J; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Home T; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Hyter S; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Isakova K; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Pathak HB; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Sharma P; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2023 Mar 06; Vol. 9 (1), pp. 10. Date of Electronic Publication: 2023 Mar 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Subham S; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Cancer Center, Kansas City, KS, USA.; BioEngineering Program, University of Kansas, Lawrence, KS, USA., Jeppson JD; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., Worcester C; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Schatmeyer B; Department of Neurosurgery, University of Kansas Medical Center, Kansas City, KS, USA., Zhao J; Department of Cancer Biology, University of Kansas Cancer Center, Kansas City, KS, USA., Madan R; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Lakis NS; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Kimler BF; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., McGuirk JP; Department of Hematology and Stem Cell Transplantation, University of Kansas Medical Center, Kansas City, KS, USA., Chen RC; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., Stecklein SR; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Akhavan D; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA. dakhavan@kumc.edu.; Department of Cancer Biology, University of Kansas Cancer Center, Kansas City, KS, USA. dakhavan@kumc.edu.; BioEngineering Program, University of Kansas, Lawrence, KS, USA. dakhavan@kumc.edu.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jan; Vol. 197 (1), pp. 57-69. Date of Electronic Publication: 2022 Nov 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen*/genetics , Receptors, Chimeric Antigen*/therapeutic use , Triple Negative Breast Neoplasms*/therapy , Triple Negative Breast Neoplasms*/drug therapy , Brain Neoplasms*/genetics , Brain Neoplasms*/therapy , Brain Neoplasms*/secondary, Humans ; Animals ; Mice ; Cell Line, Tumor ; ErbB Receptors/genetics ; ErbB Receptors/metabolism

المؤلفون: Yoder R; University of Kansas Cancer Center, Kansas City, KS, USA., Kimler BF; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA., Staley JM; University of Kansas Cancer Center, Kansas City, KS, USA., Schwensen K; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA., Wang YY; University of Kansas Cancer Center, Kansas City, KS, USA., Finke K; Clinical Trials Shared Resource, University of Kansas Medical Center, Westwood, KS, USA., O'Dea A; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA., Nye L; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA., Elia M; Department of Internal Medicine, University of Kansas Medical Center, Lee's Summit, MO, USA., Crane G; Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS, USA., McKittrick R; Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS, USA., Pluenneke R; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, MO, USA., Madhusudhana S; Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, USA., Beck L; Tammy Walker Cancer Center, Salina Regional Health Center, Salina, KS, USA., Shrestha A; Richard & Annette Bloch Cancer Center, Truman Medical Center, Kansas City, MO, USA., Corum L; Olathe Cancer Care, Olathe Medical Center, Olathe, KS, USA., Marsico M; Department of Pharmacoepidemiology/Oncology, Merck & Co., Inc, Kenilworth, NJ, USA., Stecklein SR; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA., Godwin AK; University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Khan QJ; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA., Sharma P; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA. psharma2@kumc.edu.

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2022 Jul 11; Vol. 8 (1), pp. 80. Date of Electronic Publication: 2022 Jul 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Chapman BV; Departments of Radiation Oncology., Liu D; Biostatistics., Shen Y; Biostatistics., Olamigoke OO; Departments of Radiation Oncology., Lakomy DS; Departments of Radiation Oncology., Barrera AMG; Breast Medical Oncology and Clinical Cancer Genetics., Stecklein SR; Departments of Radiation Oncology., Sawakuchi GO; Radiation Physics., Bright SJ; Radiation Physics., Bedrosian I; Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Litton JK; Breast Medical Oncology and Clinical Cancer Genetics., Smith BD; Departments of Radiation Oncology., Woodward WA; Departments of Radiation Oncology., Perkins GH; Departments of Radiation Oncology., Hoffman KE; Departments of Radiation Oncology., Stauder MC; Departments of Radiation Oncology., Strom EA; Departments of Radiation Oncology., Arun BK; Breast Medical Oncology and Clinical Cancer Genetics., Shaitelman SF; Departments of Radiation Oncology. Electronic address: sfshaitelman@mdanderson.org.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 Feb 01; Vol. 112 (2), pp. 426-436. Date of Electronic Publication: 2021 Oct 03.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/radiotherapy , Breast Neoplasms*/surgery , Neoplasm Recurrence, Local*/genetics, BRCA1 Protein/genetics ; Cohort Studies ; Female ; Germ Cells/pathology ; Germ-Line Mutation ; Humans ; Mutation ; Retrospective Studies

المؤلفون: Chapman BV; Departments of Radiation Oncology., Liu D; Biostatistics., Shen Y; Biostatistics., Olamigoke OO; Departments of Radiation Oncology., Lakomy DS; Departments of Radiation Oncology., Barrera AMG; Breast Medical Oncology and Clinical Cancer Genetics., Stecklein SR; Departments of Radiation Oncology., Sawakuchi GO; Radiation Physics, and., Bright SJ; Radiation Physics, and., Bedrosian I; Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Litton JK; Breast Medical Oncology and Clinical Cancer Genetics., Smith BD; Departments of Radiation Oncology., Woodward WA; Departments of Radiation Oncology., Perkins GH; Departments of Radiation Oncology., Hoffman KE; Departments of Radiation Oncology., Stauder MC; Departments of Radiation Oncology., Strom EA; Departments of Radiation Oncology., Arun BK; Breast Medical Oncology and Clinical Cancer Genetics., Shaitelman SF; Departments of Radiation Oncology. Electronic address: SFShaitelman@mdanderson.org.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 Feb 01; Vol. 112 (2), pp. 437-444. Date of Electronic Publication: 2021 Sep 25.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/radiotherapy , Breast Neoplasms*/surgery , Germ-Line Mutation*/genetics, BRCA1 Protein/genetics ; Female ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Humans ; Neoplasm Recurrence, Local/genetics ; Retrospective Studies ; Treatment Outcome